Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Medicare Beneficiaries

Reports

Displaying 51 - 60 of 138. 10 per page. Page 6.

Advanced Search

ADVANCE CARE PLANNING AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES AND PRACTITIONERS: FINAL REPORT

ADVANCE CARE PLANNING AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES AND PRACTITIONERS: FINAL REPORT Fang He, PhD, Angela Gasdaska, BS, Hannah Friedman, BA, Brendan Wedehas, BS, Alexis Kirk, PhD, Ila Broyles, PhD, and SaritaL.
Research Brief

Advance Care Planning Among Medicare Fee-For-Service Beneficiaries and Practitioners: Research Brief

Advance Care Planning Among Medicare Fee-For-Service Beneficiaries and Practitioners: Research Brief Fang He, PhD; Angela Gasdaska, BS; Hannah Friedman, BA; Brendan Wedehase, BS; Alexis Kirk, PhD; Ila Broyles, PhD; Sarita L.
ASPE Issue Brief

Medicare Beneficiary Use of Telehealth Visits: Early Data From the Start of the COVID-19 Pandemic

This ASPE issue brief examines changes in Medicare fee-for-service primary care visits and use of telehealth at the start of the COVID-19 public health emergency (PHE). This brief seeks to address the issue of how and whether the Medicare telehealth flexibilities introduced to address the COVID-19 pandemic may have helped maintain access to primary health care during the PHE.
ASPE Issue Brief

The Special Diabetes Program for Indians: Estimates of Medicare Savings

Between 1996 and 2013, there was a 54% decrease in the incidence of diabetes-related end-stage renal disease (ESRD-DM) in American Indian and Alaska Native (AI/ AN) populations. This decline has occurred since the Special Diabetes Program for Indians (SDPI) was established in 1997.
ASPE Issue Brief

Assessing the Costs and Benefits of Extending Coverage of Immunosuppressive Drugs under Medicare

By statute, the majority of patients with end-stage renal disease (ESRD) are eligible for Medicare, regardless of age. Kidney transplantation is ultimately considered the best treatment for ESRD, but ESRD-related eligibility for Medicare coverage extends for only 36 months post-transplant.

Loss of Medicare-Medicaid Dual Eligible Status: Frequency, Contributing Factors and Implications

Printer Friendly Version in PDF Format (32 PDF pages)
ASPE Issue Brief

Transitions in Care and Service Use among Medicare Beneficiaries in Inpatient Psychiatric Facilities Issue Brief

Medicare beneficiaries in inpatient psychiatric facilities (IPFs) have complex conditions that require sustained engagement with physical and mental health care providers. People who receive care from IPFs are at risk for a range of negative health outcomes, but surprisingly little is known about their patterns of care.

Patterns of Care and Home Health Utilization for Community-Admitted Medicare Patients

This study conducted exploratory analyses to develop a better understanding of community-admitted Medicare home health patients, including whether there have been any differential trends between community-admitted and post-acute care (PAC) patients over time and what their patterns of care tell us about the underlying reasons for the community-admitted increased numbers.

Tracking the Impact of Ownership Changes in Hospice Care Provided to Medicare Beneficiaries: Final Report

This study examines hospice ownership in detail by going beyond the general distinction of for-profit or not-for-profit and considers the extent to which regional or national chains have entered the hospice provider market and how the populations they care for and the services they provide might be distinct from other types of hospice agencies.

Comparison of U.S. and International Prices for Top Medicare Part B Drugs by Total Expenditures

The prices charged by drug manufacturers to wholesalers and distributors (commonly referred to as exmanufacturers prices) in the United States are 1.8 times higher than in other countries for the top drugs by total expenditures separately paid under Medicare Part B. U.S. prices were higher for most of the drugs included in the analysis, and U.S.